June 2024
P3 Research laboratory attended the ASM microbe 2024 conference and presented their research during this productive meeting!
Lots of ideas to work on and so many interesting talks!
May 2024
Big congratulations to P3 Research laboratory for the recent RO3 funding!
Thank you NIH for funding our RO3 grant focused on In vitro Pharmacokinetic/pharmacodynamic models for dose de-escalation of antibiotics.
April 2024
We presented highlights of P3 Research Laboratory in Biofilm interest group at OSU!
We have two BSPS undergraduate students joining our lab for summer research!
We are wishing best of luck for Corrin in her graduate studies!
February 2024
We welcome Isaac Baldridge to our group!
Welcome to the team Isaac!
January 2024
Congratulations to P3 Research Laboratory for two accepted abstracts at American Society of Microbiology!
Very excited to present our research at ASM!
- Combating Daptomycin Resistance in Multi-drug Resistant Staphylococcus aureus Strains Using Adjunctive Bacteriophage Therapy-Anja Steinert
- Targeting Staphylococcus aureus Strains Using Novel Bacterial Topoisomerase Inhibitors (NBTI’s)-Prakhar Srivastava
November 2023
Casey Madison and Anja Steinert’s poster won the poster award at the College of Pharmacy Research Day! Congratulations Casey and Anja!
Razi Presented a summary of P3 Research Laboratory work on Research Day at the College of Pharmacy!
“The Arms Race Between Bacteriophages and Antibiotics”
Welcome to U.S. Antibiotic Awareness Week(November 18-24th) – a time set aside to raise awareness of the importance of appropriate antibiotic & antifungal use & the threat of #AntimicrobialResistance across the #OneHealth spectrum.
September 2023
New publication!
Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin
Kebriaei et al., Journal of Infectious Diseases and Therapy
Prakhar is here….
Welcome to the team Prakhar! We are very excited to have you in our team!
August 2023
Alyssa and Anja are joining our team. Welcome to the team!
Congratulations to Jordan for transitioning to a new position. We will miss you Jordan!
July 2023
Congratulations to P3RL for receiving IDI Thematic Program Seed Grant Award!
June 2023
Congratulations to Jose Orench-Benvenutti for transitioning to a new job. We will miss you Jose!
We are in the news!
Recent publication:
Kunz Coyne, A.J.; Stamper, K.; Kebriaei, R.; Holger, D.J.; El Ghali, A.; Morrisette, T.; Biswas, B.; Wilson, M.; Deschenes, M.V.; Canfield, G.S.; Duerkop, B.A.; Arias, C.A.; Rybak, M.J. Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility. Antibiotics 2022, 11, 1175. https://doi.org/10.3390/antibiotics11091175
May 2023
P3 Research Laboratory is welcoming a new PhD student!
Welcome to the team Alexandra Partey!
Congratulations Jose Orench-Benvenutti for your accepted recent publication!
- Current therapies and challenges for the treatment of Staphylococcus aureus biofilm-related infections
Thanks to our amazing collaborators Dr. Tran, Dr. Morrisette and Dr. Jorgensen!
April 2023
Accepted publications of April:
1. Kebriaei, R., Lehman, S.M., Shah, R., Stamper, K., Kunz Coyne, A. J., Holger, D.J., El Ghali, A., Rybak M.J., Phage-antibiotic Co-therapy Composition Optimization: Empirical Screening Approach. Spectrum Microbiology, (proof stage)
2. Morrisette T., Stamper K., Lev K., Kebriaei, R., Holger D., Abdul-Mutakabbir J., Kunz Coyne A., and Rybak M.J., Evaluation of Omadacycline Alone and in Combination with Rifampin Against Staphylococcus aureus and Staphylococcus epidermidis in an In-Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model, AAC, (proof stage)
3. Mc Leod, C., Tan, K., Kebriaei, R., Abdul-Mutakabbir J.C., Clinical Appraisal of Cefiderocol in the Treatment of Non-Fermenting Gram-Negative Bacilli, Current Infectious Disease Reports. https://doi.org/10.1007/s11908-023-00800-0,
4. Fabijan, A.P., Iredell, J., Danis-Woldarcyk K., Kebriaei R., Abedon S.T., Translating phage therapy into the clinic: Recent accomplishments but continuing challenges, PLoS, (Proof stage)
March 2023
Paper of the month!
Each month we select a published paper to discuss in our journal club!
February 2023
P3 Research Laboratory is welcoming a new research assistant!
Welcome to the team Casey Madison!
January 2023
Recent Papers:
- Kunz Coyne, A. J., Stamper, K., Kebriaei, R., Holger, D. J., El Ghali, A., Morrisette, T., Biswas, B., Wilson, M., Deschenes, M. V., Canfield, G. S., Duerkop, B. A., Arias, C. A., & Rybak, M. J. (2022). Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility. Antibiotics, 11(9), Article 9. https://doi.org/10.3390/antibiotics11091175
- Kebriaei, R., & Berti, A. D. (2022). Editorial: Antibiotics Special Issue on Pharmacokinetic/Pharmacodynamic Models of Antibiotics. Antibiotics, 11(11), Article 11. https://doi.org/10.3390/antibiotics11111540
- Kebriaei, R., Bayer, A. S., Lapitan, C. K., Rybak, M. J., Somerville, G. A., & Mishra, N. N. (2022). Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model. Antibiotics, 11(10), 1409. https://doi.org/10.3390/antibiotics11101409